Converting-Enzyme Inhibition in the Management of Patients with Severe Chronic Congestive Heart Failure
Although converting-enzyme inhibition has become an established approach to the treatment of patients with severe chronic heart failure , it is not clear how clinicians should identify patients who are likely to benefit from treatment with these drugs. Can pretreatment hemodynamic variables predict response? Can the initial effect of treatment predict long-term efficacy? Can hormonal variables predict clinical benefits? In this chapter we shall address these important issues.
Unable to display preview. Download preview PDF.